Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …

Objectives Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen,
causes infection in patients undergoing immunosuppressive therapy, mechanical …

Treatment approaches for severe Stenotrophomonas maltophilia... : Current Opinion in
Infectious Diseases Treatment approaches for severe Stenotrophomonas maltophilia infections …

Background: Stenotrophomonas maltophilia (S. maltophilia) is an emerging opportunistic
Gram-negative rod causing nosocomial infections predominantly in immunocompromised …

Background: Ventilator-associated pneumonia (VAP) caries a morbidity and mortality risk in
the preterm neonate, particularly in the context of rising global antimicrobial resistance …

Background/Objectives: Intestinal colonization by multidrug-resistant (MDR) bacteria is
considered one of the main risk factors for invasive infections in the hematopoietic stem-cell …

Stenotrophomonas maltophilia (S. maltophilia) is a difficult-to-treat bacteria. This glucose
non-fermenting, multidrug-resistant Gram-negative bacillus is known to cause a range of …

Objectives Stenotrophomonas maltophilia, a Gram-negative non-fermentative bacillus, has
emerged as an important nosocomial pathogen in recent years. It is intrinsically resistant to …

The aim of this review is to synthesise the key aspects of the epidemiology, current
microbiological diagnostic challenges, antibiotic resistance rates, optimal antimicrobial …

Purpose To better guide clinical use, we determined the in vitro antimicrobial activity of the
new drug eravacycline and other tetracycline derivatives against levofloxacin (LVFX)-non …